Over the past week, Richard has been making calls with different investor groups.
A few notables I have heard is that he thinks the PIQ Endometriosis test could be on the market within 18 months. The test could be priced as high as $1000. As the invasive test for Endo costs >$3000 it makes sense.
Richard is going to US for 2 weeks early Sept to spend time with Sonic and getting ready for soft launch of test in the market in October.
Will do major institutional roadshow on his return mid September.
Expect news on other jurisdictions for Promarker D in the near term.
News on OC tests also in near term. Pricing and insurance payor news also in near term.
Looks like the share price is ready to launch. Selling pressure has eased.
Top 20 own 40% looking at today’s FY report.
PIQ Price at posting:
82.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)